<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180112038319N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-10-27</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the efficiency of nutrition with entera meal and Ensure and standard gavage of hospital in traumatic patients</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the efficiency of nutrition with entera meal standard formula and Ensure and standard gavage of hospital in traumatic patients at ICU in Vali-Asr hospital, Arak.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>66</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/30346</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization technique: Simple randomization with randomization table.
Patients with similar situation will be chosen. Each patient has a number. The numbers are in randomization table and 66 numbers will be chosen randomly. All the patients have equal chances. Unit of Randomization is person. Researcher and data analyser know the number of patients but they don't know the formula of each patient, Blinding description: This clinical trial will be performed in double blind way That means researcher,data analyser,nurses, hospital personnel and the patient don't know the formula. The formula will be prepared and coded  in clean room and will be given to the researcher who gives them to the patients. The preparator knows the formula and others don't know. Data Monitoring Commmittee possess all patient's data.</study_design>
      <phase>N/A</phase>
      <hc_freetext>traumatic patients.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: Entera meal standard formula _ Dose and number of times is due to nutritional need of each patient. Duration of use is 14  days for each patient. Intervention 2: Second Intervention group: Ensure formula _ Dose and number of times is due to nutritional need of each patient. Duration of use is 14 days for each patient. Intervention 3: Control group:  Standard gavage of hospital _ Dose and number of times is due to nutritional need of each patient. Duration of use is 14  days for each patient.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All The data can be shared after personal unidentification

When:
3 months after Edition of results

To whom:
Researchers-University professors-Students

Conditions:
Do not change The data.
Use for new clinical trials.

Where to obtain:
Dr Behnam Mahmoudieh  b.mahmodie@arakmu.ac.ir

How to obtain:
Call Dr Mahmoudieh

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shima Shahri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 3815163686, nastaran apartment, shahid bazjoo alley, shariati sq, Arak</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3815163686</zip>
        <telephone>+98 86 3221 8317</telephone>
        <email>sh.shahri@arakmu.ac.ir</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behnam Mahmoudieh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali-asr hospital., vali-asr sq., Arak</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>38149_5_7558</zip>
        <telephone>+98 86 3222 2003</telephone>
        <email>b.mahmodie@arakmu.ac.ir</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18 to 50
Need to Nutrition with NG tube or Gastrostomy or Jejunostomy
Multiple trauma</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Death
Gavage intolerance for more than 24 hours
Patient re-NPO for more than 24 hours
Reaction to Folate
History of DM, hyper or hypothyroidism and metabolic disease
Sensitivity to milk protein
Gastro-intestinal fistula
Burning
Renal failure
Hepatic failure</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T79.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified early complication of trauma</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: Entera meal standard formula _ Dose and number of times is due to nutritional need of each patient. Duration of use is 14  days for each patient</i_keyword>
      <i_keyword>Second Intervention group: Ensure formula _ Dose and number of times is due to nutritional need of each patient. Duration of use is 14 days for each patient</i_keyword>
      <i_keyword>Control group:  Standard gavage of hospital _ Dose and number of times is due to nutritional need of each patient. Duration of use is 14  days for each patient</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Serum total protein level: Serum albumin and globulin measurement. Timepoint: Serum total protein measurement at the beginning of trial(first day) and 8 and 14 days after Formula beginning. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Mid arm circumflex. Timepoint: Mid arm circumflex measurement at the beginning of trial(first day) and 8 and 14 days after Formula beginning. Method of measurement: non-stretchable  tape  measure.</prim_outcome>
      <prim_outcome>Serum electrolytes: (Na, K, Ca, Mg). Timepoint: Serum electrolytes  measurement at the beginning of trial(first day) and 8 and 14 days after Formula beginning. Method of measurement: Blood serum test.</prim_outcome>
      <prim_outcome>NUTRIC score: This factor is designed to quantify the risk of critically ill patients developing adverse events at ICU. It determined with the table(age_APACHE score_SOFA score_ number of co-morbidities_days from hospital to ICU admission). Timepoint: NUTRIC score  determination at the beginning of trial(first day) and 8 and 14 days after Formula beginning. Method of measurement: NUTRIC score table.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Side effect: diarrhea/Vomiting/Sensitivity. Timepoint: Complication incidence at the beginning of trial(first day) and 8 and 14 days after Formula beginning. Method of measurement: Patient physical examination.</sec_outcome>
      <sec_outcome>Final price of each formula. Timepoint: end of fourteenth day. Method of measurement: Calculation the price of formula.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-12-02</approval_date>
        <contact_name>Ethics committee of Arak University of Medical Sciences</contact_name>
        <contact_address>Arak University of Medical Sciences,basij Sq Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
